|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"楊志新"
Showing items 71-120 of 209 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2014 |
Chlorhexidine for the prevention of bloodstream infection associated with totally implantable venous ports in patients with solid cancers
|
Kao, Hsiang-Fong; Chen, I-Chun; Hsu, Chiun; Chang, Sin-Yuan; Chien, Shu-Fen; Chen, Yee-Chun; Hu, Fu-Chang; Yang, James Chih-Hsin; Cheng, Ann-Lii; Yeh, Kun-Huei; 楊志新; 高祥豐; 陳怡君; 鄭安理; 許駿; 葉坤輝; 陳宜君 |
| 國立臺灣大學 |
2014 |
Bcl-2-Like Protein 11 Deletion Polymorphism Predicts Survival in Advanced Non-Small-Cell Lung Cancer
|
Lee, Jih-Hsiang; Lin, Yu-Lin; Hsu, Wei-Hsun; Chen, Hsuan-Yu; Chang, Yeun-Chung; Yu, Chong-Jen; Shih, Jin-Yuan; Lin, Chia-Chi; Chen, Kuan-Yu; Ho, Chao-Chi; Laio, Wei-Yu; Yang, Pan-Chyr; Yang, James Chih-Hsin; 林家齊; 楊志新; 張允中; 楊泮池; 陳冠宇; 余忠仁; 林育麟; 何肇基; 施金元; 李日翔 |
| 國立臺灣大學 |
2014 |
The impact of diabetes mellitus on early cervical cancer in Asia: A population-based cohort study
|
Kuo, Hung-Yang; Lin, Zhong-Zhe; Kuo, Raymond Nienchen; Shau, Wen-Yi; Lai, Chiu-Lin; Yang, Yen-Yun; Shao, Yu Yun; Hsu, Chiun; Chang, Wen-Fang; Chang, Ann-Lii; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 鄭安理; 許駿; 賴秋伶 |
| 國立臺灣大學 |
2014 |
Epidermal growth factor receptor mutation analysis in previously unanalyzed histology samples and cytology samples from the phase III Iressa Pan-ASia Study (IPASS)
|
Yang, James Chih-Hsin; Wu, Yi-Long; Chan, Valorie; Kurnianda, Johan; Nakagawa, Kazuhiko; Saijo, Nagahiro; Fukuoka, Masahiro; McWalter, Gael; McCormack, Rose; Mok, Tony S. K.; 楊志新 |
| 國立臺灣大學 |
2014 |
Treatment of Advanced Non-Small-Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation or ALK Gene Rearrangement: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology
|
Gridelli, Cesare; de Marinis, Filippo; Cappuzzo, Federico; di Maio, Massimo; Hirsch, Fred R.; Mok, Tony; Morgillo, Floriana; Rosell, Rafael; Spigel, David R.; Yang, James Chih-Hsin; Ciardiello, Fortunato; 楊志新 |
| 國立臺灣大學 |
2014 |
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin, C-C; Su, W-C; Yen, C-J; Hsu, C-H; Su, W-P; Yeh, K-H; Lu, Y-S; Cheng, A-L; Huang, D. C-L; Fritsch, H.; Voss, F.; Taube, T.; Yang, J. C-H; 林家齊; 楊志新; 盧彥伸; 鄭安理; 徐志宏; 葉坤輝 |
| 國立臺灣大學 |
2014 |
Development of Renal Cysts after Crizotinib Treatment in Advanced ALK-Positive Non-Small-Cell Lung Cancer
|
Lin, Yen-Ting; Wang, Yu-Fen; Yang, James Chih-Hsin; Yu, Chong-Jen; Wu, Shang-Gin; Shih, Jin-Yuan; Yang, Pan-Chyr; 楊志新; 楊泮池; 余忠仁; 林奕廷; 吳尚俊; 施金元; 王郁棻 |
| 國立臺灣大學 |
2013 |
ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors
|
Huang, Cheng-Po; Tsai, Meng-Feng; Chang, Tzu-Hua; Tang, Wei-Chien; Chen, Su-Yu; Lai, Hsiao-Hsuan; Lin, Ting-Yu; Yang, James Chih-Hsin; Yang, Pan-Chyr; Shih, Jin-Yuan; Lin, Shwu-Bin; 楊志新; 楊泮池; 林淑萍; 施金元 |
| 國立臺灣大學 |
2013 |
First-Line Management of EGFR-Mutated Advanced Lung Adenocarcinoma: Recent Developments
|
Liao, Bin-Chi; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新 |
| 國立臺灣大學 |
2013 |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Wu, Shang-Gin; Yu, Chong-Jen; Tsar, Meng-Feng; Liao, Wei-Yu; Yang, Chih-Hsin; Jan, I-Shiow; Yang, Pan-Chyr; Shin, Jin-Yuan; 楊志新; 詹一秀; 楊泮池; 廖唯昱; 余忠仁 |
| 國立臺灣大學 |
2013 |
Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas
|
Wu, Pei-Fang; Huang, Wen-Chang; Yang, James Chih-Hsin; Lu, Yen-Shen; Shih, Jin-Yuan; Wu, Shang-Gin; Lin, Ching-Hung; Cheng, Ann-Lii; 楊志新; 盧彥伸; 鄭安理; 吳尚俊; 施金元; 林璟宏 |
| 國立臺灣大學 |
2013 |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Tsai, Tzu-Hsiu; Yang, Ching-Yao; Ho, Chao-Chi; Liao, Wei-Yu; Jan, I-Shiow; Chen, Kuan-Yu; Wang, Jann-Yuan; Ruan, Sheng-Yuan; Yu, Chong-Jen; Yang, James Chih-Hsin; Yang, Pan-Chyr; Shih, Jin-Yuan; 楊志新; 詹一秀; 楊泮池; 廖唯昱; 陳冠宇; 余忠仁; 何肇基; 阮聖元; 蔡子修; 王振源; 施金元 |
| 國立臺灣大學 |
2013 |
Comparison of gefitinib and erlotinib efficacies as third-line therapy for advanced non-small-cell lung cancer
|
Shao, Yu-Yun; Shau, Wen-Yi; Lin, Zhong-Zhe; Chen, Ho-Min; Kuo, Raymond; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲 |
| 國立臺灣大學 |
2013 |
Radiofrequency Ablation Is Superior to Ethanol Injection in Early-Stage Hepatocellular Carcinoma Irrespective of Tumor Size
|
Lin, Zhong-Zhe; Shau, Wen-Yi; Hsu, Chiun; Shao, Yu-Yun; Yeh, Yi-Chun; Kuo, Raymond Nien-Chen; Hsu, Chih-Hung; Yang, James Chih-Hsin; Cheng, Ann-Lii; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲; 鄭安理; 徐志宏; 許駿 |
| 國立臺灣大學 |
2013 |
Impact of EGFR Inhibitor in Non-Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
|
Lee, Chee Khoon; Brown, Chris; Gralla, Richard J.; Hirsh, Vera; Thongprasert, Sumitra; Tsai, Chun-Ming; Tan, Eng Huat; Ho, James Chung-Man; Chu, Da Tong; Zaatar, Adel; Osorio Sanchez, Jemela Anne; Vu, Vu Van; Au, Joseph Siu Kie; Inoue, Akira; Lee, Siow Ming; Gebski, Val; Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2013 |
Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: An open-label single-arm study
|
Chang, Gee-Chen; Tsai, Chun-Ming; Hsia, Te-Chun; Yang, Chih-Hsin; Abdulnabi, Radhi; Blair, Julie M.; Linn, Carlos; 楊志新 |
| 國立臺灣大學 |
2013 |
MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib
|
Huang, Ming-Hung; Lee, Jih-Hsiang; Chang, Ya-Ju; Tsai, Hsin-Hui; Lin, Yu-Lin; Lin, Anya Maan-Yuh; Yang, James Chih-Hsin; 楊志新; 林育麟; 李日翔 |
| 國立臺灣大學 |
2013 |
Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR Mutations
|
Yang, James Chih-Hsin; Hirsh, Vera; Schuler, Martin; Yamamoto, Nobuyuki; O'Byrne, Kenneth J.; Mok, Tony S. K.; Zazulina, Victoria; Shahidi, Mehdi; Lungershausen, Juliane; Massey, Dan; Palmer, Michael; Sequist, Lecia V.; 楊志新 |
| 國立臺灣大學 |
2013 |
Epidermal growth factor receptor (EGFR)-mediated adverse events (AEs) in patients (pts) with EGFR mutation positive (EGFR M plus ) non-small cell lung cancer treated with afatinib
|
Yang, J. Chih-Hsin; Sequist, L.; O'Byrne, K.; Schuler, M.; Mok, T.; Geater, S.; Massey, D.; O'Brien, D.; Zazulina, V.; Wu, Y. L.; 楊志新 |
| 國立臺灣大學 |
2013 |
EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancer
|
Kao, Hsiang-Fong; Lin, Chia-Chi; Yang, James Chih-Hsin; 林家齊; 楊志新; 高祥豐 |
| 國立臺灣大學 |
2013 |
Diarrhea associated with afatinib: an oral ErbB family blocker
|
Yang, James Chih-Hsin; Reguart, Noemi; Barinoff, Jana; Koehler, Jens; Uttenreuther-Fischer, Martina; Stammberger, Uz; O'Brien, Dennis; Wolf, Juergen; Cohen, Ezra E. W.; 楊志新 |
| 國立臺灣大學 |
2013 |
Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study
|
Wu, Yi-Long; Fukuoka, Masahiro; Mok, Tony S. K.; Saijo, Nagahiro; Thongprasert, Sumitra; Yang, James C. H.; Chu, Da-Tong; Yang, Jin-Ji; Rukazenkov, Yuri; 楊志新 |
| 國立臺灣大學 |
2013 |
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
|
Sequist, Lecia V.; Yang, James Chih-Hsin; Yamamoto, Nobuyuki; O'Byrne, Kenneth; Hirsh, Vera; Mok, Tony; Geater, Sarayut Lucien; Orlov, Sergey; Tsai, Chun-Ming; Boyer, Michael; Su, Wu-Chou; Bennouna, Jaafar; Kato, Terufumi; Gorbunova, Vera; Lee, Ki Hyeong; Shah, Riyaz; Massey, Dan; Zazulina, Victoria; Shahidi, Mehdi; Schuler, Martin; 楊志新 |
| 國立臺灣大學 |
2012 |
EML4-ALK Translocation Predicts Better Outcome in Lung Adenocarcinoma Patients with Wild-Type EGFR
|
Wu, Shang-Gin; Kuo, Yao-Wen; Chang, Yih-Leong; Shih, Jin-Yuan; Chen, Ya-Hui; Tsai, Meng-Feng; Yu, Chong-Jen; Yang, Chih-Hsin; Yang, Pan-Chyr; 楊志新; 張逸良; 楊泮池; 余忠仁; 郭耀文; 吳尚俊; 施金元; 陳盈憲 |
| 國立臺灣大學 |
2012 |
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial
|
Yang, James Chih-Hsin; Shih, Jin-Yuan; Su, Wu-Chou; Hsia, Te-Chun; Tsai, Chun-Ming; Ou, Sai-Hong Ignatius; Yu, Chung-Jen; Chang, Gee-Chen; Ho, Ching-Liang; Sequist, Lecia V.; Dudek, Arkadiusz Z.; Shahidi, Mehdi; Cong, Xiuyu Julie; Lorence, Robert M.; Yang, Pan-Chyr; Miller, Vincent A.; 楊志新; 楊泮池; 余忠仁; 施金元 |
| 國立臺灣大學 |
2012 |
Effusion Immunocytochemistry as an Alternative Approach for the Selection of First-Line Targeted Therapy in Advanced Lung Adenocarcinoma
|
Tsai, Tzu-Hsiu; Wu, Shang-Gin; Chang, Yih-Leong; Wu, Chen-Tu; Tsai, Meng-Feng; Wei, Pin-Fei; Yang, Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr; Shih, Jin-Yuan; 吳振都; 楊志新; 張逸良; 楊泮池; 余忠仁; 衛品妃; 吳尚俊; 蔡子修; 施金元 |
| 國立臺灣大學 |
2012 |
Genetic Polymorphism of XRCC1 Arg399Gln Is Associated With Survival in Non-Small-Cell Lung Cancer Patients Treated With Gemcitabine/Platinum
|
Liao, Wei-Yu; Shih, Jin-Yuan; Chang, Gee-Chen; Cheng, Yu-Kai; Yang, James Chih-Hsin; Chen, Yuh-Min; Yu, Chong-Jen; 楊志新; 廖唯昱; 余忠仁; 施金元 |
| 國立臺灣大學 |
2012 |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang, Yeun-Chung; Yu, Chong-Jen; Chen, Chung-Ming; Hu, Fu-Chang; Hsu, Hao-Hsiang; Tseng, Wen-Yih I.; Shih, Tiffany Ting-Fang; Yang, Pan-Chyr; Yang, James Chih-Hsin; 曾文毅; 楊志新; 陳中明; 張允中; 施庭芳; 楊泮池; 余忠仁; 胡賦強 |
| 國立臺灣大學 |
2012 |
Factors Impacting Prognosis Prediction in BCLC Stage C and Child-Pugh Class A Hepatocellular Carcinoma Patients in Prospective Clinical Trials of Systemic Therapy
|
Lin, Zhong-Zhe; Hsu, Chiun; Hu, Fu-Chang; Shao, Yu-Yun; Chang, Dwan-Ying; Yang, Chih-Hsin; Hong, Ruey-Long; Hsu, Chih-Hung; Cheng, Ann-Lii; 楊志新; 邵幼雲; 林宗哲; 鄭安理; 徐志宏; 洪瑞隆; 許駿; 胡賦強; 張端瑩 |
| 國立臺灣大學 |
2012 |
Advanced non-small cell lung cancer in patients aged 45 years or younger: outcomes and prognostic factors
|
Hsu, Chia-Lin; Chen, Kuan-Yu; Shih, Jin-Yuan; Ho, Chao-Chi; Yang, Chih-Hsin; Yu, Chong-Jen; Yang, Pan-Chyr; 楊志新; 楊泮池; 許嘉林; 陳冠宇; 余忠仁; 何肇基; 施金元 |
| 國立臺灣大學 |
2012 |
Survival Following Surgery with or without Adjuvant Chemotherapy for Stage I-IIIA Non-Small Cell Lung Cancer: An East Asian Population-Based Study
|
Lin, Zhong-Zhe; Shau, Wen-Yi; Shao, Yu-Yun; Yang, Yen-Yun; Kuo, Raymond Nien-Chen; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲 |
| 國立臺灣大學 |
2012 |
Survival of Patients with Small Cell Lung Carcinoma in Taiwan
|
Kuo, Yu-Hsuan; Lin, Zhong-Zhe; Yang, Yen-Yun; Shao, Yu-Yun; Shau, Wen-Yi; Kuo, Raymond N. C.; Yang, James Chih-Hsin; Lai, Mei-Shu; 楊志新; 邵幼雲; 賴美淑; 林宗哲; 郭年真 |
| 國立臺灣大學 |
2012 |
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma
|
Girard, N.; Sima, C. S.; Jackman, D. M.; Sequist, L. V.; Chen, H.; Yang, J. C-H.; Ji, H.; Waltman, B.; Rosell, R.; Taron, M.; Zakowski, M. F.; Ladanyi, M.; Riely, G.; Pao, W.; 楊志新 |
| 國立臺灣大學 |
2012 |
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial
|
Miller, Vincent A.; Hirsh, Vera; Cadranel, Jacques; Chen, Yuh-Min; Park, Keunchil; Kim, Sang-We; Zhou, Caicun; Su, Wu-Chou; Wang, Mengzhao; Sun, Yan; Heo, Dae Seog; Crino, Lucio; Tan, Eng-Huat; Chao, Tsu-Yi; Shahidi, Mehdi; Cong, Xiuyu Julie; Lorence, Robert M.; Yang, James Chih-Hsin; 楊志新 |
| 國立臺灣大學 |
2011 |
Comparison of the Quality of Life between Patients with Non-Small-Cell Lung Cancer and Healthy Controls
|
李俊賢; 張郁瑩; 李元麒; 楊志新; 劉紹興; 劉邦祥; 王榮德; LEE, LUKAS JYUHN-HSIARN; CHANG, YU-YIN; LEE, YUNG-CHIE; YANG, CHIH-HSIN; LIOU, SAOU-HSING; LIU, PANG-HSIANG; WANG, JUNG-DER |
| 國立臺灣大學 |
2011 |
Tumour Response, Skin Rash and Health-Related Quality of Life (Hrqol) - Post-Hoc Data from the Ipass Study
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2011 |
Skin Manifestations of Gefitinib and the Association with Survival of Advanced Non-Small-Cell Lung Cancer in Taiwan
|
王修含; 楊志新; 邱顯清; 胡賦?; 詹智傑; 廖怡華; 陳小菁; 朱家瑜; WANG, SHIOU-HAN; YANG, CHIH-HSIN; CHIU, HSIEN-CHING; HU, FU-CHANG; CHAN, CHIH-CHIEH; LIAO, YI-HUA; CHEN, HSIAO-CHIN; CHU, CHIA-YU |
| 國立臺灣大學 |
2011 |
Inspire: A Phase Iii Study of the Blp25 Liposome Vaccine (L-Blp25) in Asian Patients with Unresectable Stage Iii Non-Small Cell Lung Cancer
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2011 |
Phase 2 Trial of Linifanib (Abt-869) in Patients with Advanced Non-Small Cell Lung Cancer
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2011 |
Vandetanib Plus Pemetrexed for the Second-Line Treatment of Advanced Non- Small-Cell Lung Cancer: A Randomized, Double-Blind Phase Iii Trial
|
楊志新; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2011 |
Health-Related Quality-of-Life in a Randomized Phase Iii First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients from Asia with Advanced Nsclc (Ipass)
|
楊志新; 陳育民; 郭漢彬; YANG, CHIH-HSIN; CHEN, YUH-MIN; KUO, HAN-PIN |
| 國立臺灣大學 |
2011 |
Biomarker Analyses and Final Overall Survival Results from a Phase Iii, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/ Paclitaxel in Clinically Selected Patients with Advanced Non-Small-Cell Lung Cancer in Asia (Ipass)
|
楊志新; 趙祖怡; YANG, CHIH-HSIN; CHAO, TSU-YI |
| 國立臺灣大學 |
2010 |
Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors
|
陳冠宇; 陳人豪; 施金元; 楊志新; 余忠仁; 楊泮池; CHEN, KUAN-YU; CHEN, JEN-HAU; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YU, CHONG-JEN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
O-6-Methylguanine-DNA Methyltransferase Expression and Prognostic Value in Brain Metastases of Lung Cancers
|
吳佩芳; 郭冠廷; 郭律廷; 林怡婷; 盧彥伸; 楊志新; 吳瑞美; 杜永光; 蔡瑞章; 曾漢民; 曾勝弘; 鄭安理; 林璟宏; WU, PEI-FANG; KUO, KUAN-TING; KUO, LU-TING; LIN, YI-TING; LU, YEN-SHEN; YANG, CHIH-HSIN; WU, RUEY-MEEI; TU, YONG-KWANG; TSAI, JUI-CHANG; TSENG, HAN-MIN; TSENG, SHENG-HONG; CHENG, ANN-LII; LIN, CHING-HUNG |
| 國立臺灣大學 |
2010 |
Characteristics and Risk Factors of Oxaliplatin-Related Hypersensitivity Reactions
|
邵幼雲; 胡賦强; 邱文姿; 鄭安理; 楊志新; SHAO, YU-YUN; HU, FU-CHANG; CHIU, WEN-TZU; CHENG, ANN-LII; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2010 |
Chemotherapy Response in East Asian Non-Small Cell Lung Cancer Patients Harboring Wild-Type or Activating Mutation of Epidermal Growth Factor Receptors
|
林家齊; 徐心馨; 孫家棟; 施金元; 林宗哲; 余忠仁; 楊志新; LIN, CHIA-CHI; HSU, HSIN-HSIN; SHUN, CHIA-TUNG; SHIH, JIN-YUAN; LIN, ZONG-ZHE; YU, CHONG-JEN; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2010 |
Correlation of F-18 Fluorodeoxyglucose-Positron Emission Tomography Maximal Standardized Uptake Value and Egfr Mutations in Advanced Lung Adenocarcinoma
|
黃俊達; 顏若芳; 鄭媚方; 衛品妃; 蔡怡汝; 蔡孟峰; 施金元; 楊志新; 楊泮池; HUANG, CHUN-TA; YEN, RUOH-FANG; CHENG, MEI-FANG; WEI, PIN-FEI; TSAI, YI-JU; TSAI, MENG-FENG; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
Influence of First-Line Chemotherapy and Egfr Mutations on Second-Line Gefitinib in Advanced Non-Small Cell Lung Cancer
|
巫震宇; 余忠仁; 施金元; 楊志新; 楊泮池; WU, JENN-YU; YU, CHONG-JEN; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
Second-Line Treatments after First-Line Gefitinib Therapy in Advanced Nonsmall Cell Lung Cancer
|
巫震宇; 施金元; 楊志新; 陳冠宇; 何肇基; 余忠仁; 楊泮池; WU, JENN-YU; SHIH, JIN-YUAN; YANG, CHIH-HSIN; CHEN, KUAN-YU; HO, CHAO-CHI; YU, CHONG-JEN; YANG, PAN-CHYR |
| 國立臺灣大學 |
2010 |
Use of Cetuximab after Failure of Gefitinib in Patients with Advanced Non- Small-Cell Lung Cancer
|
巫震宇; 楊志新; 余忠仁; 楊泮池; 施金元; WU, JENN-YU; YANG, CHIH-HSIN; YU, CHONG-JEN; SHIH, JIN-YUAN; YANG, PAN-CHYR |
Showing items 71-120 of 209 (5 Page(s) Totally)
<< < 1 2 3 4 5 > >>
View [10|25|50] records per page
|
